Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INV-102 in Moderate to Severe Dry Eye Disease
NCT06370039Phase 2Completed
- Sponsor
- Invirsa
- Start
- Mar 2024
- Primary completion
- Jul 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of INV-102 in dry eye disease (DED), sponsored by Invirsa. Started Mar 2024; status: completed.
02
Drugs
INV-102
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06370039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06370039.